What types of clinical interventions do pharmacists carry out in hospitals for patients receiving palliative care?

References

• World Health Organization (WHO). National cancer control programmes: policies and managerial guidelines. 2nd ed. Geneva: World Health Organization; 2002.
   Google Scholar
• O'Connor M, Fisher C, Guilfoyle A. Interdisciplinary teams in palliative care: a critical reflection. Int J Palliat Nurs 2006;12(3):132–7. doi:10.12968/ijpn.2006.12.3.20698.
   PubMedGoogle Scholar
• World Health Organization (WHO). Palliative care for noncommunicable diseases: a global snapshot – 2020. 1st ed. Geneva: World Health Organization; 2020.
   Google Scholar
• Pinderhughes ST, Lehn JM, Kamal AH, Hutchinson R, O'Neill L, Jones CA. Expanding palliative medicine across care settings: one health system experience. J Palliat Med 2018;21(9):1272–7. doi:10.1089/jpm.2017.0375.
   PubMed Web of Science ®Google Scholar
• Pairojkul S, Thongkhamcharoen R, Raksasataya A, Sorasit C, Nakawiro P, Sudsa S, et al. Integration of specialist palliative care into Tertiary Hospitals: a multicenter point prevalence survey from Thailand. Palliat Med Rep 2021;2(1):272–9. doi:10.1089/pmr.2021.0003.
   PubMedGoogle Scholar
• Orzechowski R, Galvão AL, Nunes TDS, Campos LS. Palliative care need in patients with advanced heart failure hospitalized in a tertiary hospital. Rev Esc Enferm USP 2019;53:e03413. doi:10.1590/S1980-220X2018015403413.
   PubMed Web of Science ®Google Scholar
• Oluyase AO, Higginson IJ, Yi D, Pazin-Filho A. Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review. 1st ed. Southampton: NIHR Journals Library; 2021.
   Google Scholar
• Lourençato Miranda FM, de Carvalho CH, Borges M, Moravec M, Hanouskova K, Knizek-Bonatto M. Palliative care team in a Brazilian tertiary emergency department. Int J Emerg Med 2022;15:53. doi:10.1186/s12245-022-00456-y.
   PubMed Web of Science ®Google Scholar
• Kremenova Z, Svancara J, Kralova P, Moravec M, Hanouskova K, Knizek-Bonatto M. Does a hospital palliative care team have the potential to reduce the cost of a terminal hospitalization? A retrospective case-control study in a Czech Tertiary University Hospital. J Palliat Med 2022;2 5(7):1088–94. doi:10.1089/jpm.2021.0529.
   Google Scholar
• Herndon CM, Nee D, Atayee RS, Craig DS, Lehn J, Moore PS., et al. ASHP guidelines on the pharmacists role in palliative and hospice care. Am J Health-Syst Pharm 2016;73:1351–67. doi:10.2146/ajhp160244.
   PubMed Web of Science ®Google Scholar
• Moody JJ, Poon IO, Braun UK. The role of an inpatient hospice and palliative clinical pharmacist in the interdisciplinary team. Am J Hosp Palliat Care 2022;39(7):856–64. doi:10.1177/10499091211049401.
   PubMed Web of Science ®Google Scholar
• Correr CJ, Melchiors AC, de Souza T, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother 2013;47(7-8):946–52. doi:10.1345/aph.1S006.
   PubMed Web of Science ®Google Scholar
• Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005;8(1):19–32. doi:10.1080/1364557032000119616.
   Google Scholar
• Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. JBI Evid Implement 2015;13(3):141–6. doi:10.1097/XEB.0000000000000050.
   Google Scholar
• Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan - a web and mobile app for systematic reviews. Syst Rev 2016;5:210. doi:10.1186/s13643-016-0384-4.
   PubMed Web of Science ®Google Scholar
• Ministério da Saúde, Brasil. Cuidado Farmacêutico na Atenção Básica: aplicação do método clinico. 1st ed. Brasília: Secretaria de Atenção Primária à Saúde; 2020.
   Google Scholar
• Uchida M, Suzuki S, Sugawara H, Suga Y, Kokubun H, Uesawa Y, et al. A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan. J Pharm Health Care Sci 2019;5:14. doi:10.1186/s40780-019-0143-5.
   PubMed Web of Science ®Google Scholar
• Ise Y, Morita T, Katayama S, Kizawa Y. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan. J Pain Symptom Manage 2014;47(3):588–93. doi:10.1016/j.jpainsymman.2013.05.008.
   PubMed Web of Science ®Google Scholar
• Myotoku M, Murayama Y, Nakanishi A, Hashimoto N, Koyama F, Irishio K, et al. Assessment of palliative care team activities–survey of medications prescribed immediately before and at the beginning of opioid usage. Yakugaku Zasshi 2008;128(2):299–304. doi:10.1248/yakushi.128.299.
   PubMed Web of Science ®Google Scholar
• Maeyama E, Kawa M, Miyashita M, Ozawa T, Futami N, Nakagami Y, et al. Multiprofessional team approach in palliative care units in Japan. Support Care Cancer 2003;11(8):509–15. doi:10.1007/s00520-003-0465-5.
   PubMed Web of Science ®Google Scholar
• Kurozumi Y, Oishi S, Sugano Y, Sakashita A, Kotooka N, Suzuki M, et al. Possible associations between palliative care conferences and positive outcomes when performing palliative care for patients with end-stage heart failure: a nationwide cross-sectional questionnaire survey. Heart Vessels 2019;34(3):452–61. doi:10.1007/s00380-018-1261-y.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Matsui M, Inoue R, Uchino N. Potentially inappropriate medication discontinued or changed based on pharmacists’ recommendations in older end-stage cancer patients receiving palliative care: a cross-sectional study. Ann Palliat Med 2021;10(11):11301–7. doi:10.21037/apm-21-1788.
   PubMed Web of Science ®Google Scholar
• Kihara A, Shimada K, Tsuneto S. How do we taper and discontinue opioids in cancer patients? Considerations from the activities of a palliative care team at a University Hospital. Palliat Med Rep 2021;2(1):255–9. doi:10.1089/pmr.2020.0105.
   PubMedGoogle Scholar
• Lehn JM, Gerkin RD, Kisiel SC, O'Neill L, ST P. Pharmacists providing palliative care services: demonstrating a positive return on investment. J Palliat Med 2019;22(6):644–8. doi:10.1089/jpm.2018.0082.
   PubMed Web of Science ®Google Scholar
• Atayee RS, Sam AM, Edmonds KP. Patterns of palliative care pharmacist interventions and outcomes as part of inpatient palliative care consult service. J Palliat Med 2018;21(12):1761–7. doi:10.1089/jpm.2018.0093.
   PubMed Web of Science ®Google Scholar
• Foxwell AM, Moyer ME, Casarett DJ, Connor O, R N. Palliative care office hours for patients with hematologic malignancies: an innovative model for symptom management and education. J Palliat Med 2017;20(10):1148–51. doi:10.1089/jpm.2017.0091.
   PubMed Web of Science ®Google Scholar
• Naidu D, Jones K, Kanyer D, Hausdorff J. Palliative care pharmacist interventions in a community hospital. Am J Health Syst Pharm 2018;75(13):933–6. doi:10.2146/ajhp170250.
   PubMed Web of Science ®Google Scholar
• Suh ES, Bartlett G, Inguanti M, Folstad J. Evaluation of a pharmacist pain management education program and associated medication use in a palliative care population. Am J Health Syst Pharm 2004;61(3):277–80. doi:10.1093/ajhp/61.3.277.
   PubMed Web of Science ®Google Scholar
• Kumar PS, Saphire ML, Grogan M, Benedict J, Janse S, Agne JL, et al. Substance abuse risk and medication monitoring in patients with advanced lung cancer receiving palliative care. J Pain Palliat Care Pharmacother 2021;35(2):91–9. doi:10.1080/15360288.2021.1920545.
   PubMed Web of Science ®Google Scholar
• Malotte K, Naidu DR, Herndon CM, Atayee RS. Multicentered evaluation of palliative care pharmacists’ interventions and outcomes in California. J Palliat Med 2021;24(9):1358–63. doi:10.1089/jpm.2020.0566.
   PubMed Web of Science ®Google Scholar
• Crul M, Oosterhof P. The oncology pharmacist as part of the palliative treatment team. Int J Pharm Pract 2020;28(1):92–6. doi:10.1111/ijpp.12583.
   PubMed Web of Science ®Google Scholar
• Geum MJ, Ahn JH, Kim JS, Kim SH, Son ES, Hu YJ, et al. Interprofessional collaboration between a multidisciplinary palliative care team and the team pharmacist on pain management. Am J Hosp Palliat Care 2019;36(7):616–22. doi:10.1177/1049909119829047.
   PubMed Web of Science ®Google Scholar
• Lloyd-Williams M, Payne S. Can multidisciplinary guidelines improve the palliation of symptoms in the terminal phase of dementia? Int J Palliat Nurs 2002;8(8):370–5. https://doi.org/10.12968/ijpn.2002.8.8.10680.
   PubMedGoogle Scholar
• Lucas C, Glare PA, Sykes JV. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit. Palliat Med 1997;11(3):209–16. doi:10.1177/026921639701100305.
   PubMed Web of Science ®Google Scholar
• McQuillar R, Finlay I, Roberts D, Branch C, Forbes K, Spencer MG. The provision of a palliative care service in a teaching hospital and subsequent evaluation of that service. Palliat Med 1996;10(3):231–9. doi:10.1177/026921639601000307.
   PubMed Web of Science ®Google Scholar
• Wilby KJ, Mohamad AA, AlYafei SA. Evaluation of clinical pharmacy services offered for palliative care patients in Qatar. J Pain Palliat Care Pharmacother 2014;28(3):212–5. doi:10.3109/15360288.2014.938884.
   PubMedGoogle Scholar
• Dufort-Rouleau C, Martin B, Barré V, Bédard V, Rouleau ÉD, Beauchesne MF, et al. Conformity in prescription and administration of respiratory distress protocols in a tertiary care hospital in the Province of Quebec: RELIEVE study. J Palliat Care 2020;35(1):21–8. doi:10.1177/0825859719835555.
   PubMed Web of Science ®Google Scholar
• Håkonsen GD, Strelec P, Campbell D, Hudson S, Loennechen T. Adherence to medication guideline criteria in cancer pain management. J Pain Symptom Manage 2009;37(6):1006–18. doi:10.1016/j.jpainsymman.2008.06.006.
   PubMed Web of Science ®Google Scholar
• Adisa R, Anifowose AT. Pharmacists’ knowledge, attitude and involvement in palliative care in selected tertiary hospitals in southwestern Nigeria. Bmc Palliat Care 2019;18:107. doi:10.1186/s12904-019-0492-8.
   PubMed Web of Science ®Google Scholar
• Saunders S, Dersch-Mills D, Mysak T, Romonko-Slack L, Chernick A, Lazarenko G, et al. CAPABLE: Calgary zone usage of additional prescribing authorization by pharmacists in an inpatient setting: review of the prescribing Landscape and Environment. Res Social Adm Pharm 2020;16(3):342–8. doi:10.1016/j.sapharm.2019.05.021.
   PubMed Web of Science ®Google Scholar
• Hanley J, Spargo M, Brown J, Magee J. The development of an enhanced palliative care pharmacy service during the initial COVID-19 surge. Pharmacy (Basel) 2021;9(4):196. doi:10.3390/pharmacy9040196.
   PubMedGoogle Scholar
• Hong S, Lee JH, Chun EK, Kim KI, Kim JW, Kim SH, et al. Polypharmacy, inappropriate medication use, and drug interactions in older Korean patients with cancer receiving first-line palliative chemotherapy. Oncologist 2020;25(3):e502–11. doi:10.1634/theoncologist.2019-0085.
   PubMed Web of Science ®Google Scholar
• Murnane JM, Passlow CA, Arnold M, McCormick CP. Safe prescribing and preparation of continuous subcutaneous infusions in a regional palliative care unit. J Pharm Pract 2013;43(2):109–11. doi:10.1002/j.2055-2335.2013.tb00231.x.
   Google Scholar
• Tuffaha HW, Koopmans SM. Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. J Oncol Pharm Pract 2012;18(2):180–5. doi:10.1177/1078155211416529.
   PubMedGoogle Scholar
• Clelland D, van Steijn D, Whitelaw S, Connor S, Centeno C, Clark D. Palliative care in public policy: results from a global survey. Palliat Med Rep 2020;1(1):183–90. doi:10.1089/pmr.2020.0062.
   PubMedGoogle Scholar
• Hughes MT, Smith TJ, Mark TH. The growth of palliative care in the United States. Annu Rev Public Health 2014;35:459–75. https://doi.org/10.1146/annurev-publhealth-032013-182406.
   PubMed Web of Science ®Google Scholar
• Pastrana T, Vallath N, Mastrojohn J, Namukwaya E, Kumar S, Radbruch L, et al. Disparities in the contribution of low- and middle-income countries to palliative care research. J Pain Symptom Manage 2010;39:54–68. doi:10.1016/j.jpainsymman.2009.05.023.
   PubMed Web of Science ®Google Scholar
• Clark J, Gardiner C, Barnes A. International palliative care research in the context of global development: a systematic mapping review. BMJ Support Palliat Care 2018;8:7–18. https://doi.org/10.1136/bmjspcare-2015-001008.
   PubMed Web of Science ®Google Scholar
• Cleary J, Ddungu H, Distelhorst SR, Ripamonti C, Rodin GM, Bushnaq MA, et al. Supportive and palliative care for metastatic breast cancer: resource allocations in low-and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. The Breast 2013;22(5):616–27. doi:10.1016/j.breast.2013.07.052.
   PubMed Web of Science ®Google Scholar
• Hannon B, Zimmermann C, Knaul FM, Powell RA, Mwangi-Powell FN., Rodin G, et al. Provision of palliative care in low-and middle-income countries: overcoming obstacles for effective treatment delivery. J Clin Oncol 2016;34(1):62–8. doi:10.1200/JCO.2015.62.1615.
   PubMed Web of Science ®Google Scholar
• Abu-Odah H, Molassiotis A, Liu JYW. Global palliative care research (2002–2020): bibliometric review and mapping analysis. BMJ Support Palliat Care. Online ahead of print. doi:10.1136/bmjspcare-2021-002982
   Web of Science ®Google Scholar
• Man JP, Weinkauf JG, Tsang M, Sin JHDD. Why do some countries publish more than others? An international comparison of research funding, English proficiency and publication output in highly ranked medical journals. Eur J Epidemiol 2004;19:811–7. doi:10.1023/b:ejep.0000036571.00320.b8.
   PubMed Web of Science ®Google Scholar
• Clark D, Graham F. Evolution and change in palliative care around the world. Medicine 2011;39(11):636–8. doi:10.1016/j.mpmed.2011.08.014.
   Google Scholar
• Carter BL. Evolution of clinical pharmacy in the USA and future directions for patient care. Drugs Aging 2016;33(3):169–77. doi:10.1007/s40266-016-0349-2.
   PubMed Web of Science ®Google Scholar
• Buehler NJ, Frydman JL, Morrison RS, Gelfman LP. An update: national institutes of health research funding for palliative medicine 2016–2020. J Palliat Med 2022. Online ahead of print. doi:10.1089/jpm.2022.0316.
   PubMed Web of Science ®Google Scholar
• Sorensen TD, Pestka D, Sorge LA, Wallace ML, Schommer J. A qualitative evaluation of medication management services in six Minnesota health systems. Am J Heal Pharm 2016;73(5):307–14. doi:10.2146/ajhp150212.
   PubMed Web of Science ®Google Scholar
• Pereira CE, Bambirra EH, Fernandes BD, Sousa MC, Mendonça SA, Chemello C. Factors influencing the implementation of pharmaceutical care in outpatient settings: A systematic review applying the consolidated framework for implementation research. Res Soc Adm Pharm 2022;18(4):2579–92. doi:10.1016/j.sapharm.2021.06.011.
   PubMed Web of Science ®Google Scholar
• Kaasa S, Hjermstad MJ, Loge JH. Methodological and structural challenges in palliative care research: how have we fared in the last decades? Palliat Med 2006;20:727–34. doi:10.1177/0269216306072620.
   PubMed Web of Science ®Google Scholar
• Hasson F, Nicholson E, Muldrew D, Bamidele O, Payne S, McIlfatrick S. International palliative care research priorities: a systematic review. BMC Palliat Care 2020;19(1):1–6. https://doi.org/10.1186/s12904-020-0520-8.
   PubMed Web of Science ®Google Scholar
• Mehta AK, Patel R, Patel D, Davis MP. Trends in published palliative care research: a 15-year review. Am J Hosp Palliat Care 2021;38(5):489–93. doi:10.1177/1049909120944863.
   PubMed Web of Science ®Google Scholar
• Hui D, Parsons HA, Damani S, Fulton S, Liu J, Evans A, et al. Quantity, design, and scope of the palliative oncology literature. Oncologist 2011;16:694–703. doi:10.1634/theoncologist.2010-0397.
   PubMed Web of Science ®Google Scholar
• Visser C, Hadley G, Wee B. Reality of evidence-based practice in palliative care. Cancer Biol. Med 2015;12:193–200. doi:10.7497/j.issn.2095-3941.2015.0041.
   PubMed Web of Science ®Google Scholar
• Bouça-Machado R, Rosário M, Alarcão J, Correia-Guedes L, Abreu D, Ferreira JJ. Clinical trials in palliative care: a systematic review of their methodological characteristics and of the quality of their reporting. BMC Palliat Care 2017;16(1):1–2. https://doi.org/10.1186/s12904-016-0181-9.
   PubMedGoogle Scholar
• Aoun SM, Nekolaichuk C. Improving the evidence base in palliative care to inform practice and policy: thinking outside the box. J Pain Symptom Manag 2014;48:1222–35. doi:10.1016/j.jpainsymman.2014.01.007.
   PubMed Web of Science ®Google Scholar
• Oliveira AM, Varallo FR, Rodrigues JPV, Pereira LRL. Protocol for the implementation of pharmaceutical care in geriatrics: strategy for safety in health care. Rev Gaucha Enferm 2022 Aug 26;43:e20210236. doi: 10.1590/1983-1447.2022.20210236.en.
   PubMedGoogle Scholar
• Chimada CA, da Silva EM, Otênio JK, Pinc MM, Jesus RA Teixeira DG, et al. The importance of pharmacotherapeutic follow-up in patients with heart failure. Res Soc Dev 2020;9(10):e1949108538. doi:10.33448/rsd-v9i10.8538.
   Google Scholar
• Rémi C, Bauer D, Krumm L, Bausewein C. Drug-Related Problems on a Palliative Care Unit. J Pain Palliat Care Pharmacother 2021: 1–9. doi:10.1080/15360288.2021.1943596.
   PubMed Web of Science ®Google Scholar
• DiScala SL, Onofrio S, Miller M, Nazario M, Silverman M. Integration of a clinical pharmacist into an interdisciplinary palliative care outpatient clinic. Am J Hosp Palliat Care 2017;34(9):814–9. doi:10.1177/1049909116657324.
   PubMed Web of Science ®Google Scholar
• Mota KD, Baldoni AO, Baptista EC, Reis TM, Pereira LRL, Nascimento MMG, et al. Profile of activities developed by community pharmacists: do they corroborate the precepts of the pharmaceutical profession? Braz J Pharm Sci 2020;56:e18472. doi:10.1590/s2175-97902020000118472.
   Web of Science ®Google Scholar
• World Health Organization (WHO). Global Atlas Palliat Care. 2nd ed. London: Worldwide Palliative Care Alliance; 2020.
   Google Scholar
• Fried TR, O'Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014;62(12):2261–72. doi:10.1111/jgs.13153.
   PubMed Web of Science ®Google Scholar
• Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. J Gerontol A Biol Sci Med Sci 2015;70:989–95. doi:10.1093/gerona/glv013.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Medication Safety in Polypharmacy. 1st ed. Geneva: World Health Organization; 2019.
   Google Scholar
• Rankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2018;9:CD008165. doi:10.1002/14651858.CD008165.pub4.
   PubMed Web of Science ®Google Scholar
• de Oliveira AM, Varallo FR, Rodrigues JPV, Aguilar GJ, da Costa Lima NK, Leira Pereira LR, et al. Contribution of pharmaceutical care to person-centered health care and the safety of pharmacotherapy for hospitalized older individuals in Brazil: an investigative single-arm intervention trial. Curr Drug Saf 2023;18(2):253–63. doi: 10.2174/1574886317666220614140433.
   PubMed Web of Science ®Google Scholar
• Verdoorn S, Kwint H-F, Blom JW, Gussekloo J, Bouvy ML. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: a randomised controlled trial (DREAMeR-study). Plos Med 2019;16(5):e1002798. doi:10.1371/journal.pmed.1002798.
   PubMed Web of Science ®Google Scholar